Synapsoft logo
AI Insights from Disclosures
Searching...
AbClon Inc. 174900
Searching...

Company Summary

Quarterly Performance Revenue Operating Margin

Market Sentiment

※ Click the graph to view AI analysis information for that month.
Revenue
Consolidated
Separate
Operating Income
Consolidated
Separate
Net Income
Consolidated
Separate

Financials

Excel

No financial data is available for this period.
~
Quarterly
Annual
No data is available for this period.

*Values beyond the fourth decimal place of the unit are displayed as '0/-0'

Financial Indicator Forecast

※ These forecasts are simple AI estimates based on historical data and may differ from actual results.

Company Overview

as of June 2026
AbClon Inc. is a biotech venture company founded in 2010 through the joint participation of a group of Korean scientists with innovative antibody technology and a group of Swedish scientists with advanced biotechnology, for the development of antibody therapeutics. Unlike other biotech companies, the company has a process that enables it to continuously derive novel antibody drug candidates based on its innovative antibody discovery platform.
Representative Director Lee Jongseo
Founded June 25, 2010
Corporation Type KOSDAQ
Industry Classification Manufacture of medical supplies and related other medicaments
Corporate number 11011-4379213
Business number 113-86-40428
Phone Number 02-2109-1294
Fax Number 02-2109-1296
Website www.abclon.com
Company Address 285 Digital-ro, Guro-gu, Seoul
Products & Services

Financial Health

Executives

Employees

Shareholders

Industry revenue

Disclosures

Comments

0 / 255

AI Assistant